Sales & Marketing Views & Analysis

Views & Analysis

Is the pharma gender gap starting to close?

When Emma Walmsley took the reins of GlaxoSmithKline (GSK) in 2016, becoming the first woman to head up a major pharmaceutical company, it was headline news.

Views & Analysis

AstraZeneca may have hit rock bottom, but can it rise to new...

Back in 2014, Pascal Soriot CEO of AstraZeneca managed to stave off a takeover bid from Pfizer with a bold promise to return the company to growth and achieve revenues of between $41 to $42 billion

Views & Analysis

Brand planning in complex and uncertain markets

In our first article we addressed the modern challenges to strategic planning; the growing complexity and uncertainty that presents challenges to creating a comprehensive and coherent vision of the

Sales & Marketing

Group of young multiracial woman with red ribbons in hands are struggling against HIV/AIDS. AIDS awareness concept.

Are dual ARVs the new frontier in a maturing HIV market?

Tackling and managing HIV has been one of the pharmaceutical industry’s more distinguished achievements, despite the turbulence and antagonism that marked the early days of AIDS-related R&D and

Views & Analysis

Strategic planning in increasingly complex and uncertain mar...

This article is the first in a series of three from Osprey Health Consulting that address the contemporary challenges facing strategic brand planners dealing with increasingly complex and uncertain

Podcasts